Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Ticker SymbolKMDA
Company nameKamada Ltd
IPO dateAug 01, 2005
CEOMr. Amir London
Number of employees374
Security typeOrdinary Share
Fiscal year-endAug 01
Address2 Holtzman St., Science Park
CityREHOVOT
Stock exchangeNASDAQ Global Select Consolidated
CountryIsrael
Postal code7670402
Phone97289406472
Websitehttps://www.kamada.com/
Ticker SymbolKMDA
IPO dateAug 01, 2005
CEOMr. Amir London
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data